TO ASSESS THE FINANCIAL IMPACT OF MULTIDRUG RESISTANT ORGANISMS IN ADULT CRITICALLY ILL PATIENTS AT A TERTIARY CARE HOSPITAL
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 25
- 试验地点
- 1
- 主要终点
- To analyze the inpatient cost of intensive care unit stay associated with multidrug-resistant organisms in critically ill adult patients
研究概览
简要总结
As per the World Health Organization (WHO) fact sheet, infections by antimicrobial-resistant organisms can result in failure of treatment, increased cost of medical treatment, increased hospitalization stay and increased socioeconomic burden, there have not been any Indian study substantiating the escalated financial burden and resource utilization. Multiple indirect evidences like increased antibiotics consumption, prolonged length of ICU stay and increased mortality rate have been pointers towards the need for an Indian study which could highlight the magnanimity of the problem.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Cases- Patients who develop infection with multidrug resistant organisms from the day of admission to discharge from the intensive care unit.
- •Patients above 18years of age
- •Controls- patients admitted to intensive care unit who do not have infection with multidrug resistant organisms
- •Both medical and surgical patients.
排除标准
- •Patients with consent for comfort care.
结局指标
主要结局
To analyze the inpatient cost of intensive care unit stay associated with multidrug-resistant organisms in critically ill adult patients
时间窗: 3 months
次要结局
未报告次要终点
研究者
Sr Dr Malti Flawrance MBBS MD IDCCM
St.Johns Medical College Hospital bengaluru